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Background: Plasmodium ovale is responsible for 5% of imported malaria in French travellers. The clinical and
biological features of six clustered cases of P. ovale malaria in an army unit of 62 French soldiers returning from the
Ivory Coast are reported.
Case report: All patients were symptomatic and developed symptoms on average 50 days after their return and
20 days after the end of chemoprophylaxis (doxycycline). Clinical features included fever (6/6), mostly tertian (4/6),
aches (6/6), nausea (3/6), abdominal pain (2/6), diarrhoea (2/6), or cough (2/6). Thrombocytopaenia was lower than
100,000/mm
3 in half the cases only, and the haemoglobin count was normal for all patients. The diagnosis was
made after at least three thick and thin blood smear searches. Parasitaemia was always lower than 0.5%. All rapid
diagnostic tests were negative for HRP2 and pLDH antigens.
Discussion: Plasmodium ovale malaria is currently a problem to diagnose in travellers, notably in French soldiers
returning from the Ivory Coast. Early attempts at diagnosis are difficult due to the lack of specific clinical features,
the rarity of biological changes and the poor sensitivity of diagnostic tools to detect low parasitaemia. Thus, the
diagnosis is commonly delayed or missed. Physicians should be aware of this diagnostic challenge to avoid
relapses and provide prompt and adequate treatment with chloroquine and radical cure with primaquine.
Background
Malaria is a threat to travellers staying in tropical endemic
areas, including soldiers under field conditions [1,2]. Each
year, 40,000 French soldiers stay in or go through malaria-
infected areas, using mandatory mosquito-fighting mea-
sures and chemoprophylaxis (currently doxycycline). In
2006, the French Army experienced 557 cases of malaria,
60% of which were due to Plasmodium falciparum [3].
About half of these malarial attacks were diagnosed in sol-
diers after their return from endemic areas [3]. Continu-
ous monitoring identified a recent increase in imported
non-falciparum malaria, mainly Plasmodium vivax from
French Guiana and Plasmodium ovale from West Africa
[3,4]. This is a report of six clustered cases of imported
P. ovale malaria in French soldiers who were infected in
the Ivory Coast, pointing out the difficulties in diagnosing
this species.
Cases report
Six cases of P. ovale malaria were successively diagnosed
among French soldiers returning from the Ivory Coast.
They all belonged to the same army unit (62 people),
which had stayed in Abijdan, Bouake and Yamoussoukro
between 01/10/2007 and 15/04/2008. During the mis-
sion, this unit suffered 16 cases of fevers of unknown
origin (two of them included in the cases reported
here), but no malarial attack confirmed by rapid anti-
genic tests. An epidemiological study with behavioural
questionnaire was conducted in the unit among the
cases and uninfected soldiers. The incidence rate for
malarial infection was 6/62 (10%) over 6.5 months. All
the patients admitted having imperfectly used anti-
mosquito measures, but all declared having correctly
taken doxycycline chemoprophylaxis during the mission
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tistically associated with the occurrence of malaria in
this small group.
All infected cases were men (mean age: 32 years,
range: 30-36). The first symptoms developed on average
50 days after their return (range: 41-72) and an average
of 20 days after the end of chemoprophylaxis (range:
11-42). The patients consulted on average two days after
the onset of symptoms. The most frequent symptoms
were fever (6/6), mostly tertian (4/6) with temperatures
higher than 38.5°C in half the cases, aches (6/6) and shi-
vers (5/6). Other symptoms included nausea (3/6),
abdominal pain (2/6), diarrhoea (2/6), or cough (2/6).
No patient had a splenomegaly. Biological changes
(Table 1) included thrombocytopaenia lower than
100,000/mm
3 (3/6), hepatic cytolysis (3/6), hyperbilirubi-
naemia (1/6), and elevated CRP (6/6). The haemoglobin
count was normal for all patients.
The diagnosis was established using thick and thin
blood smears, after at least three searches for each case
(up to seven times for one case), and on average eight
days after the onset of symptoms (range: 3-12). Parasi-
taemia was always lower than 0.5%. Rapid diagnostic
tests were all negative both for the HRP2 antigen (speci-
ficity for P. falciparum) and for the pLDH antigen (spe-
cificity for Plasmodium spp, thus for P. ovale).
Three patients received chloroquine (25 milligrams/
kilo within three days). Three patients received quinine
(24 mg/kg/d for seven days) because of suspected co-
infection with P. falciparum (two cases) or digestive
intolerance (one case treated by intravenous quinine).
All attacks were cured. One patient experienced a
P. ovale relapse 30 days after his first attack. He received
a further course of chloroquine. All patients also
received a course of primaquine (15 mg/d for 14 days)
to avoid malarial relapse, none having a glucose-6-phos-
phate-dehydrogenase (G6PD) deficiency. No new relapse
was reported after a 24-month follow-up.
Discussion
For travellers, P. falciparum is the main target of malar-
ial prevention because this species is widely endemic,
very common and clinically severe [1]. Although very
rarely life-threatening, relapsing malaria species, P. vivax
and P. ovale, are also of concern for travellers in ende-
mic areas. In contrast to P. vivax, which is widespread
in Asia and Central and Southern America, P. ovale is
only endemic in some African countries [5]. Two sub-
species of P. ovale have been identified in West Africa
[6]. Plasmodium ovale is responsible for rare, travel-
acquired infection [7]. However, the French Army
experienced a significant increase in the incidence rate
of P. ovale malaria attacks among French soldiers
returning from the Ivory Coast between 2002 and 2007,
but not among soldiers in the field, while the incidence
of Pl. falciparum regularly decreased over the same per-
iod [3,4]. These changes could reflect epidemiological
changes in the local transmission of malaria and/or a
lower effectiveness of doxycycline chemoprophylaxis on
P. ovale than on P. falciparum.I n d e e d ,P. ovale was
Table 1 Delays and biological changes in 6 French soldiers with imported Plasmodium ovale malaria.
Patient 1 2 3456
Number of days between end of chemoprophylaxis and disease onset 19 18 11 12 42 17
Number of days between onset and diagnosis 8 5 12 11 3 7
Haemoglobin (g/dL)
[Normal = 13-18 g/dL]
13.2 13.0 13.9 15.1 14.1 15.3
White blood count (x 10
3/mm
3)
[Normal = 4-10 × 10
3/mm
3]
6.6 5.7 5.4 2.0 8.5 5.9
Blood platelets (x 10
3/mm
3)
[Normal = 150-400 × 10
3/mm
3]
147.0 97.0 297.0 60.0 170.0 60.0
CRP (mg/L)
[Normal < 10 mg/L]
24.0 27.0 50.0 122.0 25.0 118.0
Creatinaemia (μmol/L)
[Normal = 70-100 μmol/L]
79.0 90.0 103.0 120.0 73.0 88.0
Glucose (mmol/L)
[Normal = 4-7.25 mmol/L]
5.3 6.1 6.3 6.5 4.5 6.8
ASAT (UI/L)
[Normal = 5-40 UI/L]
27.0 23.0 89.0 34.0 24.0 91.0
ALAT (UI/L)
[Normal = 5-35 UI/L]
34.0 16.0 129.0 96.0 40.0 179.0
Bilirubin (mg/L)
[Normal < 12 mg/L]
7.8 43.0 16.0 9.0 10.0 11.0
Haptoglobin (g/L)
[Normal = 1-3 g/L]
1.1 0.21 1.6 1.0 1.2 0.3
de Laval et al. Malaria Journal 2010, 9:358
http://www.malariajournal.com/content/9/1/358
Page 2 of 4very uncommon while using the association chloro-
quine-proguanil in the French Army before 2002. Thus,
preventing P. ovale infection with doxycycline seems
challenging because of the lack of action on hypno-
zoites. A similar failure has also been recently reported
with atovaquone plus proguanil chemoprophylaxis [8].
Diagnosing P. ovale infection in infected patients is a
challenge in the field or on return to non-endemic
countries [9]. Symptoms can be due to a primary infec-
tion or, later to relapses that occur in one patient in ten
because of delayed parasitaemia from intrahepatic dor-
mant forms [1]. Shortening the time-lapse before effec-
tive treatment of this relapsing malaria is required to
reduce morbidity, limit sick-leave and, diminish the risk
of spleen rupture [10]. This experience illustrates a few
traps that physicians should be aware of when attempt-
ing a diagnosis. First, all clinical features of P. ovale
attacks are not specific. Nevertheless, a tertian fever-evo-
cative although non-specific - was present in more than
half the patients, possibly due to the time lapse to the
delayed diagnosis, which had allowed synchronization of
the replication cycle. Moreover, digestive or respiratory
symptoms, which were present in half cases, can
wrongly suggest a viral infection. However, any fever,
associated or not, after return from an endemic area,
should be considered to be due to malaria and be fol-
lowed up by immediate thick and thin blood smears. As
a result of health education before and during the mis-
sion, all the patients promptly consulted a general prac-
titioner and underwent a search for malaria in a nearby
laboratory. In contrast to Plasmodium falciparum and
Plasmodium vivax malaria, the haemogram appeared
n o tt ob ev e r yh e l p f u lf o rPlasmodium ovale because
anaemia is frequently missing and thrombocytopaenia
mild or absent [7], especially within the first days of the
attack. Biological markers for haemolysis were also miss-
ing in five cases out of six. Most of all, the sensitivity of
routine microscopic searches for P. ovale in imported
cases is very low [11], as shown in this series. Although
more pyrogenic than P. falciparum [12], the level of
parasitaemia for P. ovale is far lower at the same time
after disease onset [7]. Unfortunately, all available rapid
antigenic tests currently lack sensitivity to P. ovale,
while they are highly sensitive to P. falciparum [13-15].
They generally fail to detect P. ovale infection when
thick films and blood smears are negative. This could be
due to the very low level of circulating antigen or to
inadequate antigens used for these tests. This could
explain some acute unexplained fevers in the French
Army in the field in Africa [3]. When the diagnosis of
imported P. ovale malaria is suspected, routine micro-
scopic searches with thick and thin blood smears should
be repeated, up to three times and in an expert labora-
tory, if possible [9]. Considering the high sensitivity and
specificity of molecular detection of P. ovale using PCR,
this tool marks real progress in confirming the diagno-
sis, although it is still not routinely available [5,7,16]. It
can be used as a second-line diagnosis tool to identify
infra-microscopic parasitaemia, especially for unex-
plained relapsing fever in travellers.
The treatment for proven attacks is based on chloro-
quine (25 mg/kg for three days). The treatment against
dormant stages in the liver consists of a radical cure
with primaquine (0.5 mg/kg/d for 14 days) in patients
without G6PD deficiency [17,18]. Failures of primaquine
are unusual, mostly due to poor observance or inade-
quate dosage [19].
To date, diagnosing P. ovale infection in travellers
returning from endemic areas is still a challenge for
physicians and requires repeat microscopic searches to
detect low parasitaemia. As PCR is not a routine tool,
there is a real need to improve the sensitivity of rapid
diagnostic tests for this plasmodial species.
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